Benefit of Hypothermia in OHCA Complicating AMI

Sponsor
Yonsei University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06141252
Collaborator
(none)
3,000
1
2
1.5
2029.2

Study Details

Study Description

Brief Summary

To determine the clinical effectiveness of hypothermia treatment in patients with out-of-hospital cardiac arrest complicating acute myocardial infarction.

Condition or Disease Intervention/Treatment Phase
  • Device: Hypothermia
N/A

Detailed Description

Out-of-hospital cardiac arrest (OHCA) is a leading cause of mortality worldwide. Due to significant improvement in the management of patients with OHCA, an increasing number of initially resuscitated patients are being admitted to hospitals. Nevertheless, OHCA remains associated with a poor prognosis, with a survival rate of approximately 8.8% to hospital discharge. Moreover, international registry data have indicated that favorable neurological outcome at hospital discharge or 30 days after OHCA is only 2.8-18.2% across all registries.

The majority of adult cardiac arrest cases are associated with obstructive coronary artery disease. Thus, current guideline recommended that immediate angiography and primary revascularization in all patients with resuscitated cardiac arrest and ST-segment elevation on electrocardiography, and also in patients with resuscitated cardiac arrest without ST-segment elevation, but with high probability of acute coronary occlusion. However, even after prompt restoration of blood flow, a substantial proportion of patients with myocardial infarction (MI) experience extensive necrosis. The application of hypothermia in patients with acute MI focuses on the reducing energy consumption at cardiac level, a factor consistently linked to diminished infarction size in animal study. However, in a recent meta-analysis of randomized trials comparing different strategies for therapeutic hypothermia adjunctive to percutaneous coronary intervention (PCI) versus standard of care in patients with acute MI, faille to demonstrate clear benefit. It is important to note, however, these randomized trials were underpowered and as a results, they were unable to draw firm conclusions regarding the impact of therapeutic hypothermia.

Therefore, this study aimed to investigate the impact of therapeutic hypothermia on clinical outcomes in patients who underwent primary PCI for acute MI after OHCA.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The investigators aim to compare and evaluate the effects of therapeutic hypothermia versus standard care on clinical outcomes, such as survival rates and neurological function, in patients with out-of-hospital cardiac arrest complicating acute myocardial infarction.The investigators aim to compare and evaluate the effects of therapeutic hypothermia versus standard care on clinical outcomes, such as survival rates and neurological function, in patients with out-of-hospital cardiac arrest complicating acute myocardial infarction.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Benefit of Hypothermia in Out-of-hospital Cardiac Arrest Complicating Acute Myocardial Infarction
Actual Study Start Date :
Nov 15, 2023
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hypothermia

Patients admitted with out-of-hospital cardiac arrest and treated with hypothermia

Device: Hypothermia
Patients admitted with out-of-hospital cardiac arrest and treated with hypothermia

No Intervention: No hypothermia

Patients admitted with out-of-hospital cardiac arrest and treated without hypothermia

Outcome Measures

Primary Outcome Measures

  1. Death from any cause at hospital discharge [up to 30 days]

    Death from any cause at hospital discharge

Secondary Outcome Measures

  1. Poor neurological outcomesat hospital discharge [up to 30 days]

    Poor neurological outcomes, which was defined as a Glasgow-Pittsburge Cerebral Performance Category (CPC) value at hospital discharge. The investigators determined the neurological outcome according to Pittsburgh CPC, which is a scale on 1 to 5. 1 is e.g. good cerebral performance: conscious, alert, able to work, might have mild neurological or physiological deficit contrast to 5 which is brain death.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Out-of-hospital cardiac arrest event
Exclusion Criteria:
  • Arrest of non-cardiac origin

  • Age < 18 years

  • Did not received primary PCI

  • Hypothermia before CAG

  • Obey mental status

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yongin Severance Hospitall, Yonsei University College of Medicine Yongin Gyeonggi-do Korea, Republic of 16995

Sponsors and Collaborators

  • Yonsei University

Investigators

  • Principal Investigator: Yongcheol Kim, MD, PhD, Yongin Severance Hospital, Yonsei University College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
SungA Bae, Clinical Professor, Yonsei University
ClinicalTrials.gov Identifier:
NCT06141252
Other Study ID Numbers:
  • Door-to-cooling timing in OHCA
First Posted:
Nov 21, 2023
Last Update Posted:
Nov 22, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by SungA Bae, Clinical Professor, Yonsei University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 22, 2023